Myeloid cancers, such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN)—are driven by complex genetic mutations. Accurate identification of these mutations is essential for diagnosis, prognosis, and personalized treatment planning.

The Myeloid Profiler DNA Panel is a powerful genomic tool that helps researchers and clinicians detect critical genetic variations with high precision, offering actionable insights for improved clinical outcomes.

What is Myeloid Profiler DNA Panel

The Uncoded Myeloid Profiler DNA Panel is a Next-Generation Sequencing (NGS)-based solution that targets 74 key genes implicated in myeloid malignancies.

• Comprehensive genomic coverage, including hotspot regions and full coding sequences (CDS) of relevant genes

• Advanced target enrichment techniques to ensure accuracy

• High-depth sequencing for reliable variant detection

• Ideal for use in research laboratories, clinical studies, and biomarker discover

Key Features of the Myeloid Profiler DNA Panel

• Comprehensive Gene Coverage
  Targets 75 genes, including 41 with full coding sequences (CDS), enabling in-depth detection of clinically relevant variants.

• High Sensitivity & Accuracy
  Reliably detects single nucleotide variants (SNVs), insertions and deletions (INDELs), and copy number variations (CNVs) with high analytical precision.

• Broad Sample Compatibility
  Compatible with genomic DNA (gDNA) extracted from blood and bone marrow, ensuring flexibility in clinical and research workflows.

• Optimized NGS Workflow
  Streamlined library preparation reduces hands-on time, accelerates turnaround, and increases throughput.

• Cost-Effective Solution
  Designed to lower laboratory costs by minimizing reagent use and simplifying protocols, without compromising quality.

• Integrated Bioinformatics Support
  Includes expert-level data analysis assistance for accurate, rapid, and interpretable genomic insights.